Partners for Life Sciences.Digital Healthcare.Med-Tech.Impact.
We are Life Science Vision Capital.
We are a global multi-stage investment firm focused on life sciences, healthcare, med-tech and social impact.
We support entrepreneurs from pre-seed to later-stages.
About us
We are a global multi-stage investment firm helping entrepreneurs building for the future of healthcare and life sciences from pre-seed to later stages with presence in London, Bengaluru, Tel-aviv, San Francisco and currently expanding into Oslo and Rhineland. We commit to long-term partnerships with entrepreneurs who are as passionate as we are about pushing the frontiers of innovation to contribute to a better future. We strongly believe that turning science into business is about recognizing opportunity and at Life Science Vision Capital Partners, we focus on breakthrough innovations that have the potential to solve the world's most pressing problems.
We invest in people and science to create opportunity.
Sectors
Digital Healthcare
We define Digital Health as a wide range of sectors: mHealth, Home Care, DTx, Remote Patient Monitoring and Care, Healthcare IT, Monitoring devices, I.o.T, Tele-health, Big Data, Image Processing and more.
Biotech & Bio-Pharma
Supporting breakthroughs that have the power to change the lives of billions
Med Tech
The future of medtech resides in the shifts from intervention to prevention, invasive to non-invasive and hospitals to the home.
AI, VR & Digital Twins
Building infrastructure capacity for the future of health.
"We are not giving thumbs up or down as entrepreneur pitch us their businesses rather we understand their needs, bring in external assets and help navigate complex healthcare landscape. We cross challenges together. We create companies together"
Shu Joshi, Managing Partner
Quick overview
0+
0mn
0
0k
What's new
[ditty id=9605]
Healthcare in complex.
Our strategy for selecting healthcare investments and adding value is proven and agile. We invest across stages, geographic regions, and sectors, with expertise spanning biotechnology, bio-pharma, healthcare IT, AI, DML, AR/VR, medical technology and synthetic biology.
We are active across the entire value chain of life sciences investments, from seed to later-stage, with a focus on healthcare, impact and sustainability. Each of our funds is a manifestation of our ability to recognize opportunity and unlock its potential with a dedicated team and a tailored strategic approach.
Our basic Investment principles
We typically invest between $1m to $10m over a venture’s lifetime, with a first investment between $500k to $5m.
We take minority ownership stakes, usually between 5-25%. We play from (pre-) seed funding through IPO, as long as there is a good strategic fit.
We can lead rounds or follow another investor’s lead. We prefer to syndicate deals to ensure there is sufficient working capacity for future rounds.
We are active partners and usually offer to serve on the Board of the start-ups in our portfolio.
Our goal is to transform healthcare
one investment at a time.
By supporting diverse entrepreneurs who create and build breakthrough companies and treatments.
Our Venture Studio and Accelerator
Introducing Health Incubate Venture Studio
Say ``Hi``. Health Incubate is our inhouse venture studio platform. The team’s hands-on entrepreneurial expertise contributes to the platform's global leadership in company building. We are serial entrepreneurs using a unique model to discover and nurture ground-breaking ideas for digital therapeutics, connected healthcare, medical devices and bio-therapeutics.
Portfolio
XHealth Innovation Labs
Xhealth Innovation Labs
Our partnership with NSE public listed healthcare group Aster DM Healthcare resulted in the launching of Xhealth Innovation Labs, a unique program focused on clinicians and digital healthcare startups in India and GCC.
More here: Aster DM Healthcare
Press: Economic Times, Deal Street Asia, Express Healthcare, Inc42
Our Life Science Accelerator
Launching BioLaunch Accelerator
Our life science accelerator. BL operates an accelerator to support world-class life science innovation that drives the development of new solutions by early-stage life science start-ups for the benefit of people and society.
The Startup Nation: Israel
LSV Israel Fund I
Dedicated fund for Pre-Seed/Seed/Series A investments bringing together Israeli and European ecosystems closer for advancement of healthcare and life science innovation.
Our Team
We are driven by our talented team and network. We bring together our experienced investment professionals with healthcare industry veterans to build value in breakthrough life sciences companies.
Mr. Steve Jacobs
General Partner & CFO
Steven Jacobs is General Partner and CFO. With strong Bio-pharma M&A background, Steve has previously anchored deals in excess of $10bn while working for Switzerland basedL Partner Group. His alma mater includes CalTech (USA) and Insead (France)
Mr. Shu Joshi
Managing General Partner
Shu Joshi is a seasoned fund manager with 15+ years of work experience in PE/VC, corporate strategy, mergers, acquisitions and entrepreneurial set-ups spanning across multiple geographic locations including UK, Europe, and the USA covering medical device, biopharmaceutical, and healthcare sector. His alma mater includes University College London (UK) and Stanford Graduate School of Business (USA)
Our Venture Partners, Advisors and Executive Team
Dr. Nick Ivery
Venture Advisor, UK
Dr. Satish Rath
Industry Advisor, India
Dr. K Krishanmurthy
Consultant, USA
Dr. Amit Pareekh
Consultant, UK
Mr. Pradeep K
Business Support Function, India
Ms. Aishwarya Mahesh
Social Media & Events Manager, India
Ms. Nicole Lynn
Investment Lead, UK
Are you building for the future of health & care?
We would like to hear from you.
[ditty id=9750]